However, recent studies showed that PKR activation was also involved in eIF2α/S51 phosphorylation and immunogenic cell death induced by chemo-drugs in melanoma and breast cancer cells (Giglio et al., 2018; Li et al., 2022). The gene discussed is EIF2A; the disease is breast cancer.